Based on network pharmacology, core targets (PTGS1 and PTGS2) and key ingredients (kaempferol, beta-sitosterol, stigmasterol, fumarine and frutinone A) that might play pivotal roles in treating osteoporosis were screened out. This evidence concerns the gene PTGS2 and osteoporosis.